Author: Perlman, Stanley; Vijay, Rahul
Title: MIDDLE EAST RESPIRATORY SYNDROME VACCINES Cord-id: 9w0b806e Document date: 2016_6_1
ID: 9w0b806e
Snippet: The Middle East Respiratory Syndrome-coronavirus (MERS-CoV) has infected over 1600 individuals with nearly 600 deaths since it was first identified in human populations in 2012. No anti-viral therapies or vaccines for treatment and prophylaxis are available. Here, we discuss approaches to developing MERS vaccines, including a summary of previous efforts to develop vaccines useful against human and non-human coronaviruses. A striking feature of MERS is the important role that camels have in trans
Document: The Middle East Respiratory Syndrome-coronavirus (MERS-CoV) has infected over 1600 individuals with nearly 600 deaths since it was first identified in human populations in 2012. No anti-viral therapies or vaccines for treatment and prophylaxis are available. Here, we discuss approaches to developing MERS vaccines, including a summary of previous efforts to develop vaccines useful against human and non-human coronaviruses. A striking feature of MERS is the important role that camels have in transmission. Camel vaccination may be a novel approach to preventing the human infection.
Search related documents:
Co phrase search for related documents- accurate useful and lung disease: 1
- active immunization and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
- active immunization and longitudinal study: 1
- active immunization and lung disease: 1
Co phrase search for related documents, hyperlinks ordered by date